DIATHEVA - Biomanufacturing of innovative diagnostics and reagents

Recombinant Tat Clade D

Description: Recombinant (HIV-1) Tat Clade D produced in E. coli. Productive HIV-1 replication is absolutely dependent upon the viral tat protein. In Uganda, Clades A and D are responsible for approximately 95% of HIV-1 infections.


Product type: Biologically non-active protein estimated by Up-Take and Rescue assays (positive to uptake assay but negative to rescue assay)


Peptide: Recombinant protein: HIV-1Tat Clade D - Accession number: AAP33758.1


Expression system: E.coli


DOWNLOAD PROTOCOL


 


 

Price:
‚ā¨ 240,00

Info

Tested by: Western Blotting, SDS Page, Up-Take, Rescue assays. Reacts with Anti-Tat antibodies (Monoclonal Anti-tat clone 1D9D5, Diatheva, code ANT0037).

Form: Lyophilized. The protein should be reconstituted in apirogenic sterile water or 1X PBS.

Storage buffer: Preservative 10% glycerol

 

Company certified
ISO9001
Certified N.
IT05/0576
crm@diatheva.com
Phone (+39) 0721 830605
Fax (+39) 0721 837154
 
website netcompany
P.IVA.01403060427

By navigating this website you provide your agreement to the use of cookies, which we use to improve your navigation experience and for statistical analysis. Read our Cookie Policy to learn more

Your Shopping Cart

 x 
Cart empty